Abstract
In view of the various and promising biological activities of gallic acid, we designed and prepared a series of poly-phenolic compounds carrying multi-gallic acids residues. These dimer and tetramer of gallic acids were facilely synthesized by convergent approach. Subsequently, antioxidant activity evaluation was carried out using DPPH assay, and the resulting polyphenol exerted enhanced activity to gallic acid monomer. Antiproliferative activity evaluation was performed using MTT assay with three human cancer cell lines (Hela, A549 and MCF-7) and two human normal cell lines (HEK293 and HUVEC). The cytotoxicity of the dimer and tetramer of gallic acid were higher than that of the monomer against both cancer and normal cell lines, however the cytotoxicity of the dimer and tetramer against cancer cells was much fiercer than normal cells, which resulted in better selectivity. Consequently, vanlency effects embodied in both antioxidant and antiproliferative activities of the obtained multi-gallic acid derivatives.
Keywords: Gallic acid, Polyphenol, Antioxidant activity, Antiproliferative activity, Vanlency effects, Convergent synthesis.
Letters in Drug Design & Discovery
Title:Dimer and Tetramer of Gallic Acid: Facile Synthesis, Antioxidant and Antiproliferative Activities
Volume: 11 Issue: 1
Author(s): Junzhu Pan, Dongqin Yin, Lifang Ma, Yi Zhao, Jing Zhao and Li Guo
Affiliation:
Keywords: Gallic acid, Polyphenol, Antioxidant activity, Antiproliferative activity, Vanlency effects, Convergent synthesis.
Abstract: In view of the various and promising biological activities of gallic acid, we designed and prepared a series of poly-phenolic compounds carrying multi-gallic acids residues. These dimer and tetramer of gallic acids were facilely synthesized by convergent approach. Subsequently, antioxidant activity evaluation was carried out using DPPH assay, and the resulting polyphenol exerted enhanced activity to gallic acid monomer. Antiproliferative activity evaluation was performed using MTT assay with three human cancer cell lines (Hela, A549 and MCF-7) and two human normal cell lines (HEK293 and HUVEC). The cytotoxicity of the dimer and tetramer of gallic acid were higher than that of the monomer against both cancer and normal cell lines, however the cytotoxicity of the dimer and tetramer against cancer cells was much fiercer than normal cells, which resulted in better selectivity. Consequently, vanlency effects embodied in both antioxidant and antiproliferative activities of the obtained multi-gallic acid derivatives.
Export Options
About this article
Cite this article as:
Pan Junzhu, Yin Dongqin, Ma Lifang, Zhao Yi, Zhao Jing and Guo Li, Dimer and Tetramer of Gallic Acid: Facile Synthesis, Antioxidant and Antiproliferative Activities, Letters in Drug Design & Discovery 2014; 11 (1) . https://dx.doi.org/10.2174/15701808113109990032
DOI https://dx.doi.org/10.2174/15701808113109990032 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Radiolabelled Probes Targeting Tumor Hypoxia for Personalized Medicine
Current Pharmaceutical Design The Use of Biomarkers for Bladder Cancer Diagnosis and Surveillance
Mini-Reviews in Medicinal Chemistry Oncolytic Coxsackievirus and the Mechanisms of its Effects on Cancer: A Narrative Review
Current Cancer Therapy Reviews ATP-Binding Cassette Efflux Transporters in Human Placenta
Current Pharmaceutical Biotechnology Design of New Oxazaphosphorine Anticancer Drugs
Current Pharmaceutical Design Rhenium-188 and Copper-67 Radiopharmaceuticals for the Treatment of Bladder Cancer
Mini-Reviews in Medicinal Chemistry Development of Peptide and Protein Based Radiopharmaceuticals
Current Pharmaceutical Design The Role of ABC Transporters in Protecting Cells from Bilirubin Toxicity
Current Pharmaceutical Design CETUXIMAB: From Bench to Bedside
Current Cancer Drug Targets Arsenic Trioxide Targets miR-125b in Glioma Cells
Current Pharmaceutical Design Current and Future Clinical Strategies in Colon Cancer Prevention and the Emerging Role of Chemoprevention
Current Pharmaceutical Design Insights on the Neuromodulatory Propensity of Selaginella (Sanjeevani) and its Potential Pharmacological Applications
CNS & Neurological Disorders - Drug Targets The Role for Oxidative Stress in Aberrant DNA Methylation in Alzheimer’s Disease
Current Alzheimer Research Eplerenone, a New Selective Aldosterone Blocker
Current Pharmaceutical Design Statins and Alkylphospholipids as New Anticancer Agents Targeting Lipid Metabolism
Anti-Cancer Agents in Medicinal Chemistry Effect of Prostaglandins on the Regulation of Tumor Growth
Current Medicinal Chemistry - Anti-Cancer Agents Killing Glioma ‘Stem-like’ Cells via Drug-Induced Relocation of Endosomal Urokinase Proteins
Anti-Cancer Agents in Medicinal Chemistry Isolation of a New Trypsin Inhibitor from the Faba Bean (Vicia faba cv. Giza 843) with Potential Medicinal Applications
Protein & Peptide Letters Altered Hyaluronan Biosynthesis and Cancer Progression: an Immunological Perspective
Mini-Reviews in Medicinal Chemistry Nano-Enabled Drug Delivery in Cancer Therapy: Literature Analysis Using the MeSH System
Pharmaceutical Nanotechnology